Hood, and E. P. Skaar, mBio 4:e00241-13, 2013) described the dual functions of the two terminal oxidases encoded by cydBA and qoxABCD in Staphylococcus aureus. The aerobic growth of cydB or qoxB single mutant bacteria was barely affected. However, a cydB qoxB double mutant was completely unable to respire and exhibited the small-colony variant phenotype that is typical of menaquinone and heme biosynthesis mutants. The authors found that the two terminal oxidases play a role in pathogenesis. In a systemic mouse infection model, it turned out that in the cydB mutant the bacterial burden was significantly decreased in the heart, kidneys, and liver, while in the qoxB mutant it was decreased only in the liver. These results illustrate that both terminal oxidases contribute to fitness and virulence, representing promising candidates for the development of antimicrobials.
U
nlike the respiratory system of Escherichia coli or Bacillus subtilis, that of staphylococci is not very well characterized but some details have come to light. Staphylococci possess menaquinones (MK, vitamin K 2 ) as their sole isoprenoid quinones, and there is a species-specific variation in the length of their isoprenoid side chains. The two principal menaquinones have seven or eight isoprene units and play important roles in electron transport and oxidative phosphorylation (1) . Electrons funneled through the menaquinone cycle are transferred to the terminal oxidases with the concomitant reduction of O 2 to H 2 O (Fig. 1) . Studies of the staphylococcal cytochromes suggest that these bacteria possess a branched respiratory system consisting of two or three alternative and menaquinol-dependent terminal oxidases: a cytochrome bo, a cytochrome aa 3 , and a cytochrome bd oxidase (2) . In earlier studies, a-and b-type cytochromes were found in staphylococci; however, controversial absorption maxima were postulated for the a-type cytochromes: 605 nm (3, 4), 602 nm (5, 6) , and 608 nm (7) . On the basis of the absorption maxima, there were also several b-type cytochromes described in staphylococci: cytochrome b-552, which is present in all staphylococcal species Whether Staphylococcus aureus has two or three respiratory branches is not quite clear. Clements et al. postulated the presence of three branches in S. aureus (7): the major terminal oxidase cytochrome aa 3 , cytochrome o, and cytochrome bd oxidase. Cytochrome aa 3 oxidases are usually proton pumping, as reviewed by Thöny-Meyer (11); however, it has been proposed that in S. aureus only the cytochrome bo oxidase, and not the cytochrome aa 3 (ba 3 ) oxidase, is proton pumping (12) .
Annotation of the S. aureus genome revealed two gene clusters that encode terminal menaquinol oxidases. The qoxABCD operon encodes four quinol oxidase-like subunits, which are structurally related to the large family of mitochondrial-type aa 3 terminal oxidases, to the E. coli bo quinol oxidase, and to B. subtilis caa 3 -605 cytochrome c oxidase. In B. subtilis, Qox oxidase (aa 3 -600) is predominant during vegetative growth and its deletion caused a severe reduction of tricarboxylic acid cycle fluxes and increased overflow metabolism (13) . The other terminal oxidase consists of two putative cytochrome d menaquinol oxidases: a subunit I homolog (cydA) and a subunit II homolog (cydB). The CydAB complex represents the cytochrome bd quinol oxidase (14) . Recently, it has been shown that the nonpathogenic staphylococcal species encode a pyocyanin-and cyanide-insensitive cytochrome bd quinol oxidase, while the pathogenic species, such as S. aureus, encode a sensitive variant; cyanide resistance is determined by the CydB subunit (15) . In E. coli, cytochrome bd oxidase (CydAB) is expressed under microaerobic conditions via the regulators Fnr and ArcA (14) . As no gene cluster encoding the proposed cytochrome bo oxidase has been identified so far, the existence of one is questionable.
The recent study by Hammer et al. (16) has made it obvious that under aerobic growth conditions there are probably only two terminal oxidases present in S. aureus, and they can complement each other. A cydB qoxB double mutant exhibited a severe smallcolony variant (SCV) phenotype similar to that seen in menB and hemB mutants, in which the menaquinone or heme biosynthesis pathway is blocked, causing a complete inhibition of aerobic respiration. Mutation of all terminal oxidases should produce a similar effect. Furthermore, similar to the hem mutants, the mem-brane potential was severely decreased in the cydB qoxB double mutant. These results support the conclusion that cytochromes encoded by the qox and cyd operons are the sole terminal oxidases used by S. aureus to generate a membrane potential and facilitate aerobic respiration.
Once it was confirmed that the terminal oxidases could complement each other, the next question was whether they have different roles in infection. The authors investigated the ability of the cydB and qoxB mutants to colonize the heart, kidneys, and liver by using a systemic mouse infection model. Challenging the mice with the cydB mutant resulted in decreased colonization of the heart, and challenging the mice with the qoxB mutant resulted in decreased colonization of the liver (which has already been observed earlier [17] ). These data support the idea that the cytochromes have distinct roles during pathogenesis and are not functionally redundant. Challenging the mice with the hemA mutant resulted in decreased colonization of both the heart and the liver, which is understandable, as respiration is blocked in this mutant, and the phenotypic outcome should be similar to that obtained with the cydB qoxB double mutant.
The authors also verified their results by testing noniron metalloporphyrins that inhibit the growth of many species of bacteria under iron-limited conditions (18) . These compounds are taken up by the iron-regulated heme transport system of S. aureus (Isd) and are incorporated into the cytochromes, eliminating their electron transfer activity (19, 20) . Treatment of S. aureus with gallium protoporphyrin or zinc protoporphyrin significantly reduced growth, induced the SCV phenotype, increased fermentation products, and decreased the membrane potential. The similarities of this phenotype to that of the hem mutant or the cydB qoxB double mutant suggest that the noniron metalloporphyrins inhibit aerobic respiration. Hence, the terminal oxidases present interesting potential targets for an antimicrobial strategy, with the caveat that inhibition of S. aureus respiration may favor the selection of persister cells, leading to chronic infection.
In summary, the studies by Hammer et al. provide a molecular understanding of the role of the two-branched terminal oxidases involved in systemic infection and the colonization of various organs. It would be most interesting to know why the colonization of the cydB mutant was decreased more in the heart and that of the qoxB mutant was decreased more in the liver. To answer this question, a thorough biochemical analysis of these terminal oxidases is necessary. It will be particularly interesting to learn about their affinity for oxygen and their regulation patterns under various environmental conditions.
